<DOC>
	<DOCNO>NCT02605811</DOCNO>
	<brief_summary>To investigate response temozolomide versus prophylactic cranial radiotherapy prevent brain metastasis complete partial remission limit small cell lung cancer patient .</brief_summary>
	<brief_title>Temozolomide Preventing Brain Metastases Small Cell Lung Cancer</brief_title>
	<detailed_description>We 'd like investigate 2-year incidence rate brain metastasis complete partial remission limit small cell lung cancer patient receive temozolomide 12 month 25-30Gy prophylactic cranial radiotherapy prevent brain metastasis .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>1 . Histological cytological diagnosis smallcll lung cancer histology 2 . 18 year old 3 . Eastern Cooperative Oncology Group ( ECOG ) Performance Status 2 4 . Local stage SCLC without distant metastasis 5 . After 1stline chemotherapy ( EP IP ) least 4 cycle 6 . After radical radiotherapy primary tumor lymph node drainage area : include concurrent sequence chemoradiotherapy 7 . CR PR assessment RECIST ( 1.0 ) randomize 8 . Haemoglobin 10.0 g/dl , Absolute neutrophil count ( ANC ) 1.5^9/L , platelet 100 x 10^9/L 9 . Total bilirubin 1.5 x upper limit normal ( ULN ) alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &lt; 2.5 x ULN absence liver metastasis , &lt; 5 x ULN case liver metastases 10 . Creatinine clearance 60ml/min ( calculate accord Cockcroftgault formula ) 1 . Mixed nonsmall cell lung cancer histology 2 . Neck supraclavicular lymph node metastasis 3 . Be allergic temozolomide intolerable radiotherapy 4 . Any unstable systemic disease 5 . Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>limited small cell lung cancer</keyword>
	<keyword>brain metastasis</keyword>
	<keyword>prophylactic cranial radiotherapy</keyword>
	<keyword>temozolomide</keyword>
</DOC>